OncoSec Medical Issues Annual Letter To Shareholders

OncoSec Medical Inc. , a company developing its ImmunoPulse DNA-based intratumoral cancer immunotherapy, today issued the following letter from Punit Dhillon, Presiden



from Content Keyword RSS http://ift.tt/1l40BgJ

via IFTTT